Survey for Midwives

Share your expertise by completing our survey right here:

News updates

Empowering Midwives with RSV Education: Your Contribution Matters!

Who understands the needs of midwives better than midwives themselves? As we develop educational materials focusing on RSV for midwives, your insights are crucial! Share your expertise by completing our survey right here:

This study is supported by Sanofi

RSVVW’24 Conference

RSVVW’24 Conference!

Recap of the conference, explore the impressive video.

Conference photos!

Reflecting on the conference, explore the photos.

Scientific program!

The RSV Webinar: “RSV Travels by Airplane”

During the 14th webinar of ReSViNET’s RSV Webinar Series, Prof Philippe Lemey, shared his insights on RSV Travels by Airplane. He is the senior editor of the second edition of the Phylogenetic Handbook and a two-time ERC grant awardee. Philippe is now a full Professor at the Rega Institute, KU Leuven, where he studies the evolutionary processes that shape viral genetic diversity, spanning large-scale epidemic processes as well as small-scale transmission histories and within-host evolutionary processes.

Paper of the Month: March 2024

The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus

Authors: Annefleur Langedijk et al.

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infection in young children and the second leading cause of infant death worldwide. While global circulation has been extensively studied for respiratory viruses such as seasonal influenza, and more recently also in great detail for SARS-CoV-2, a lack of global multi-annual sampling of complete RSV genomes limits our understanding of RSV molecular epidemiology. 

Article by IHI “Going viral: A new way to track RSV awareness”

We are happy to announce the release of an interesting article, authored by the experts of the IHI – Innovative Health Initiatives hedding light on our online RSV awareness tool.

RSV Dashboard 

We are proud to announce we have developed the first-ever global RSV surveillance dashboard and it is now live!

ReSViNET Foundation, in collaboration with AstraZeneca, is supporting healthcare decisions by providing transparency and accessibility to shared global RSV surveillance data. The dashboard will help simplify tracking changes in RSV seasonality globally. This will include at least 20 countries that are representative of different geographic regions from both hemispheres.

Connecting research and society

The ReSViNET Foundation is the first and leading global non-profit organisation fully committed to reducing the global burden of the Respiratory Syncytial Virus (RSV).

We collaborate with researchers, the health sector, governments, international statutory bodies, non-profit organisations and the wider civil society in an effort to coordinate actions and raise awareness about RSV infection and to tackle the challenge of RSV infection prevention and treatment.

A global health challenge

Every year, Respiratory Syncytial Virus (RSV) affects more than 33 million children under 5 years worldwide. It is one of our most significant global healthcare challenges, not only in infants, but also in older adults. ReSViNET is the first official RSV foundation and aims to provide a platform for global collaborations to raise awareness about RSV infection and stimulate the development of RSV prevention and treatment.